Literature DB >> 28119091

Functional interaction between BDNF and mGluR II in vitro: BDNF down-regulated mGluR II gene expression and an mGluR II agonist enhanced BDNF-induced BDNF gene expression in rat cerebral cortical neurons.

Shingo Suzuki1, Hisatsugu Koshimizu2, Naoki Adachi3, Hidetada Matsuoka4, Satoko Fushimi5, Junichiro Ono5, Ken-Ichi Ohta6, Takanori Miki6.   

Abstract

Accumulating evidence suggests functional interaction between brain-derived neurotrophic factor (BDNF) and metabotropic glutamate receptor (mGluR) signaling pathways in the central nervous system (CNS). To date, eight subtypes of mGluRs, mGluR1-8, have been identified, and a previous study suggested that BDNF leads to down-regulation of GluR2 mRNA in rat cerebral cortical cultures. However, precise transcriptomic effects of BDNF on other mGluRs and their cellular significance on the BDNF signaling pathway remain largely unknown. In this study, we assessed the transcriptomic effects of BDNF on mGluR1-8 in primary cultures of rat cerebral cortical neurons, and transcriptomic impacts of mGluR(s) whose expression is regulated by BDNF, on BDNF target genes. Real-time quantitative PCR (RT-qPCR) revealed that stimulation of the cultures with 100ng/mL BDNF led to marked reductions not only in the gene expression levels of mGluR2, but also in those of mGluR3, both of which belong to group II mGluRs (mGluR II). There were, on the other hand, no changes in the amounts of mGluR I (mGluR1 and 5) and III (mGluR4, 6, 7, and 8) mRNA. Further, 10ng/mL of BDNF, which mainly activates the high-affinity BDNF receptor, TrkB, but not the low-affinity receptor, p75NTR, was able to induce down-regulation of mGluR II mRNA. The BDNF-induced suppression of mGluR II was not significantly attenuated in the presence of tetrodotoxin (TTX), a blocker for voltage-gated sodium channels. In addition, on stimulation with BDNF (100ng/mL), no significant down-regulation of mGluR II mRNA was seen in cultured astrocytes, which only express the truncated form of TrkB. Finally, we assessed the transcriptomic effect of mGluR II on the expressions of BDNF target genes, BDNF and activity-regulated cytoskeleton-associated protein (Arc). LY404039, an mGluR II agonist, enhanced the BDNF-induced up-regulation of BDNF, but not Arc. On the other hand, LY341495, an mGluR II antagonist, down-regulated BDNF mRNA levels. Collectively, these observations demonstrated the detailed functional interaction between BDNF and mGluR II: Activation of mGluR II positively regulates self-induced BDNF expression, and, in turn, BDNF negatively regulates the gene expression of mGluR II in a neuronal activity-independent manner, in cortical neurons, but not in astrocytes.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  BDNF; Cerebral cortical neurons; LY404039; mGluR II; mGluR2; mGluR3

Mesh:

Substances:

Year:  2017        PMID: 28119091     DOI: 10.1016/j.peptides.2017.01.007

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  4 in total

Review 1.  Role of Brain Modulators in Neurodevelopment: Focus on Autism Spectrum Disorder and Associated Comorbidities.

Authors:  Ali K Saad; Amal Akour; Abdulla Mahboob; Salahdein AbuRuz; Bassem Sadek
Journal:  Pharmaceuticals (Basel)       Date:  2022-05-16

2.  Glu-mGluR2/3-ERK Signaling Regulates Apoptosis of Hippocampal Neurons in Diabetic-Depression Model Rats.

Authors:  Zhuo Liu; Yuanshan Han; Hongqing Zhao; Weixu Luo; Ling Jia; Yuhong Wang
Journal:  Evid Based Complement Alternat Med       Date:  2019-06-10       Impact factor: 2.629

3.  Vexin is upregulated in cerebral cortical neurons by brain-derived neurotrophic factor.

Authors:  Hisatsugu Koshimizu; Shingo Suzuki; Anna Kawai; Ryuichiro Miura; Ken-Ichi Ohta; Takanori Miki; Naoki Adachi; Hidetada Matsuoka
Journal:  Neuropsychopharmacol Rep       Date:  2020-06-19

4.  Brain-derived neurotrophic factor predominantly regulates the expression of synapse-related genes in the striatum: Insights from in vitro transcriptomics.

Authors:  Hisatsugu Koshimizu; Hidetada Matsuoka; Yoshihiro Nakajima; Anna Kawai; Junichiro Ono; Ken-Ichi Ohta; Takanori Miki; Masataka Sunagawa; Naoki Adachi; Shingo Suzuki
Journal:  Neuropsychopharmacol Rep       Date:  2021-09-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.